Locally Advanced
Showing 51 - 75 of >10,000
Esophageal Carcinoma Trial in Nanjing (Nimotuzumab, Tigio, Concurrent radiation therapy)
Enrolling by invitation
- Esophageal Carcinoma
- Nimotuzumab
- +2 more
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital of Nanjing Medical University
Sep 19, 2023
Colon Cancer, Neoadjuvant Therapy, Immunotherapy Trial in Guangzhou (Envafolimab, CAPEOX)
Recruiting
- Colon Cancer
- +2 more
-
Guangzhou, Guangdong, ChinaSun Yat-Sen University Cancer Center
Aug 26, 2023
Pabolizumab for Neoadjuvant Immunotherapy of Locally Advanced
Recruiting
- Gastric Cancer
- Gastric Adenocarcinoma
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Apr 4, 2023
Pancreas Cancer, Locally Advanced, Locally Advanced Pancreatic Adenocarcinoma Trial in Miami (Stereotactic Ablative Body
Not yet recruiting
- Pancreas Cancer
- +2 more
- Stereotactic Ablative Body Radiation (SABR)
- Tumor Treating Fields (TTF)
-
Miami, FloridaMiami Cancer Institute at Baptist Health, Inc.
Dec 27, 2022
Rectal Tumors Trial in Nanning (Tislelizumab, Capecitabine, Oxaliplatin)
Recruiting
- Rectal Neoplasms
- Tislelizumab
- +4 more
-
Nanning, Guangxi, ChinaFirst Affiliated Hospital of Guangxi Medical University
Aug 27, 2023
Pancreatic Cancer, Locally Advanced Trial in Beijing (Later-line therapy)
Recruiting
- Pancreatic Cancer
- Locally Advanced
- Later-line therapy
-
Beijing, ChinaDepartment of Medical Oncology, Peking Union Medical College Hos
Apr 10, 2023
Locally Advanced Cervical Cancer Trial in Xi'an (Zimberelimab, Albumin-bound Paclitaxel, Cisplatin)
Recruiting
- Locally Advanced Cervical Cancer
- Zimberelimab
- +2 more
-
Xi'an, Shaanxi, ChinaHongxi Zhao
Sep 20, 2023
Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1
Not yet recruiting
- Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen
- Ivosidenib 500mg
- Placebo
- (no location specified)
Nov 7, 2023
Locally Advanced or Metastatic Breast Cancer Trial in Guangzhou (SPH4336 Tablets, SPH4336 Tablets Placebo)
Not yet recruiting
- Locally Advanced or Metastatic Breast Cancer
- SPH4336 Tablets
- SPH4336 Tablets Placebo
-
Guangzhou, Guangdong, ChinaAffiliated Cancer Hospital, Sun Yat-sen University
May 8, 2023
Rectal Cancer Trial (Ketogenic Diet, Standard Diet)
Not yet recruiting
- Rectal Cancer
- Ketogenic Diet
- Standard Diet
- (no location specified)
Jul 3, 2023
Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and
Not yet recruiting
- Colorectal Neoplasms
-
Beijing, Xicheng Dis, ChinaBeijing Friendship Hospital, Capital medical University
Sep 5, 2023
Locally Advanced or Metastatic Solid Tumors Trial in Beijing (MSC-IFNa, Nab paclitaxel, Cyclophosphamide)
Recruiting
- Locally Advanced or Metastatic Solid Tumors
- MSC-IFNα
- +3 more
-
Beijing, ChinaDepartment of Biotherapeutic, Chinese PLA General Hospital
Jan 29, 2023
Gastroesophageal Junction Adenocarcinoma Trial in Beijing (Serplulimab)
Recruiting
- Gastroesophageal Junction Adenocarcinoma
-
Beijing, ChinaPeking Union Medical College Hospital
Jun 15, 2023
Pre-analytical Factors Affecting ctDNA Analysis in Early and
Recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +4 more
- Biospecimen Collection
- Electronic Health Record Review
-
Scottsdale, ArizonaMayo Clinic in Arizona
Jul 6, 2023
Rectal Cancer, Self Efficacy Trial in Boston (PATHWAYS, Enhanced usual care)
Not yet recruiting
- Rectal Cancer
- Self Efficacy
- PATHWAYS
- Enhanced usual care
-
Boston, MassachusettsMassachusetts General Hospital
Jun 22, 2023
NSCLC Trial (Sutetinib Maleate Capsule)
Not yet recruiting
- Non-small Cell Lung Cancer
- Sutetinib Maleate Capsule
- (no location specified)
Aug 18, 2023
Rectal Cancer, Locally Advanced Trial in Tunis (Chemotherapy With FOLFIRINOX ( 5 Fluorouracil, Oxaliplatine and Irinotecan),
Active, not recruiting
- Rectal Cancer
- Locally Advanced
- Chemotherapy With FOLFIRINOX ( 5 Fluorouracil, Oxaliplatine and Irinotecan)
- Radiotherapy
-
Tunis, TunisiaAmel Mezlini
May 19, 2023
MOLecuLar Signature in Locally Advanced Cervical Cancer Patients
Recruiting
- Cervical Cancer
- Tumor tissue
- Blood sample
-
Rome, ItalyPoliclinico Universitario Agostino Gemelli, IRCCS
Aug 28, 2023
Locally Advanced Non-metastatic Intrahepatic Cholangiocarcinoma, Determine Efficacy of Liver Transplantation After Neoadjuvant
Not yet recruiting
- Locally Advanced Non-metastatic Intrahepatic Cholangiocarcinoma
- Determine Efficacy of Liver Transplantation After Neoadjuvant Systemic Therapy in Patients With Locally Advanced Non-metastatic Intrahepatic Cholangiocarcinoma
- Liver Transplant
-
Newark, New Jersey
- +1 more
Nov 14, 2023
Locally Advanced Head and Neck Squamous Cell Carcinoma Trial in Tianjin (Toripalimab, Stereotactic Body Radiation Therapy
Not yet recruiting
- Locally Advanced Head and Neck Squamous Cell Carcinoma
- Toripalimab
- Stereotactic Body Radiation Therapy (SBRT)
-
Tianjin, China
- +1 more
May 16, 2023
Locally Advanced Cervical Cancer Trial in Chongqing (Candonilimab(AK104), EBRT, BT)
Recruiting
- Locally Advanced Cervical Cancer
- Candonilimab（AK104）
- +2 more
-
Chongqing, CHN, ChinaChongqing university Cancer Hospital
Jan 15, 2023
Colorectal Cancer Trial (Serplulimab + FOLFOXIRI, Radiation therapy)
Not yet recruiting
- Colorectal Cancer
- Serplulimab + FOLFOXIRI
- Radiation therapy
- (no location specified)
Oct 24, 2023